# A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist

> **NCT00231907** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 56 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FluMist
- **BIOLOGICAL:** Fluzone

## Key facts

- **NCT ID:** NCT00231907
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231907, "A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00231907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*